Do I need an in-person exam for Seroquel?

Living with bipolar disorder often requires consistent medication management, but accessing psychiatric care can be challenging. Telehealth has emerged as a convenient alternative to in-person appointments, but many patients wonder: can bipolar medications legally be prescribed through telehealth services? The answer is generally yes—with some important nuances depending on your state and specific medication.

This comprehensive guide explains the current telehealth rules for bipolar medications as of 2026, what to expect during the process, and how to ensure you’re receiving legitimate care.

The Legal Status of Telehealth Prescribing for Bipolar Medications

Bipolar Medications vs. Controlled Substances: An Important Distinction

First, it’s crucial to understand that most primary medications used to treat bipolar disorder—including lithium, lamotrigine (Lamictal), and quetiapine (Seroquel)—are not controlled substances. This classification significantly impacts how easily they can be prescribed via telehealth.

Unlike medications for ADHD (such as Adderall) or anxiety (like Xanax) which are controlled substances with strict DEA regulations, common bipolar medications:

• Are not regulated by the DEA’s special telemedicine rules
• Do not require in-person visits under federal law
• Can generally be prescribed through telehealth in all states
• Don’t require prescription monitoring program checks in most states

Dr. Sarah Henderson, Medical Director at Klarity Health, explains: ‘The non-controlled status of most bipolar medications means telehealth is a viable option for many patients who might otherwise face barriers to psychiatric care. This creates an important access point, especially for those in underserved areas.’

Current Federal Telehealth Laws (2026)

As of January 2026, federal law allows telehealth prescribing of non-controlled medications without restriction. While the DEA has extended special telehealth flexibilities for controlled substances through December 31, 2026, these rules don’t impact the core medications for bipolar disorder since they aren’t controlled.

The primary federal telehealth regulations affect:

• Non-controlled medications (including most bipolar medications): Can be prescribed via telehealth with no federal restrictions
• Controlled substances: Currently allowed via telehealth under temporary DEA flexibilities (extended through Dec 31, 2026)

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Rules for Bipolar Medications

While federal law permits telehealth prescribing of non-controlled bipolar medications, state laws add additional layers of regulation. Here’s what you need to know about key states:

California

• Telehealth prescribing: Fully permitted for non-controlled medications
• In-person requirements: None for bipolar medications
• Provider authority: NPs currently working under collaborative practice with transition to independent practice by 2026
• 2025-26 updates: AB 1503 pending to clarify telehealth exam standards

Texas

• Telehealth prescribing: Allowed for mental health medications
• In-person requirements: None for non-controlled medications
• Provider authority: NPs require physician supervision via Prescriptive Authority Agreements
• Special notes: Texas prohibits telehealth prescribing of certain controlled substances, but this doesn’t affect bipolar medications

New York

• Telehealth prescribing: Permitted for non-controlled medications
• In-person requirements: None for bipolar medications
• Provider authority: NPs have independent practice after 3,600 hours
• 2025-26 updates: New law for controlled substances requiring in-person visits (with exceptions) doesn’t affect bipolar medications

Florida

• Telehealth prescribing: Allowed for non-controlled medications
• In-person requirements: None for bipolar medications
• Provider authority: NPs must practice under physician protocols
• Special notes: Florida’s restrictions on telehealth prescribing of Schedule II controlled substances don’t impact bipolar medications

New Hampshire

• Telehealth prescribing: Permitted for non-controlled medications
• In-person requirements: Periodic (12-month) telehealth evaluation required
• Provider authority: NPs have full practice authority
• 2025-26 updates: SB 252 expanded telehealth prescribing for non-opioid Schedule II-IV medications

Pennsylvania, Illinois, Georgia, Alabama, and Delaware

All these states permit telehealth prescribing of non-controlled bipolar medications without in-person requirements, though they differ in whether NPs need physician collaboration.

Medication-Specific Telehealth Considerations

Lithium

• DEA Schedule: Unscheduled (non-controlled)
• Telehealth prescribing: Allowed federally and in all states
• Special considerations: Requires periodic blood level monitoring

At Klarity Health, providers often arrange for patients to get labs at local facilities before follow-up telehealth appointments to ensure safe lithium levels.

Lamotrigine (Lamictal)

• DEA Schedule: Unscheduled (non-controlled)
• Telehealth prescribing: Allowed federally and in all states
• Special considerations: Initial dosing must be gradual to reduce rash risk

Quetiapine (Seroquel)

• DEA Schedule: Unscheduled (non-controlled)
• Telehealth prescribing: Allowed federally and in all states
• Special considerations: Some states track in PDMP despite non-controlled status due to occasional misuse

What to Expect During Telehealth Treatment for Bipolar Disorder

The Initial Evaluation

A legitimate telehealth evaluation for bipolar disorder should include:

1. Comprehensive psychiatric assessment: Expect a thorough evaluation lasting 30-60 minutes
2. Medical history review: Including previous treatments, hospitalizations, and medication responses
3. Symptom assessment: Using standardized tools to evaluate mood episodes
4. Safety screening: Assessment for suicidal thoughts or other risks
5. Treatment planning: Discussion of medication options and potential side effects

‘A proper telehealth evaluation for bipolar disorder isn’t rushed—it’s actually often more comprehensive than brief in-person visits,’ notes Dr. Henderson. ‘At Klarity Health, our initial evaluations typically last 45-60 minutes to ensure we get a complete picture.’

Prescription Process

If medication is appropriate, your telehealth provider will:

1. Send an electronic prescription to your preferred pharmacy
2. Determine appropriate follow-up intervals (typically every 1-3 months)
3. Provide emergency contact information and crisis resources
4. Order necessary laboratory tests when indicated

Ongoing Care

Telehealth follow-up for bipolar treatment typically involves:

• Regular video appointments to monitor symptoms and medication effectiveness
• Periodic lab monitoring for medications like lithium
• Medication adjustments as needed based on response and side effects
• Coordination with therapists or other providers when appropriate

Who Is Eligible for Telehealth Bipolar Treatment?

Telehealth is most appropriate for:

• Adults with bipolar I or II in relatively stable condition or with mild-to-moderate symptoms
• Patients who can participate in video visits with adequate internet connection
• Those who can access local labs when necessary for monitoring

Situations where in-person care may be more appropriate include:

• Severe mania or psychosis requiring possible hospitalization
• Active suicidal ideation requiring immediate intervention
• Cognitive impairment that interferes with telehealth participation
• Lack of access to video capability or private space for appointments

Common Misconceptions About Telehealth and Bipolar Treatment

Myth 1: ‘Online psychiatrists can’t prescribe real medications.’

Reality: Licensed telehealth providers can prescribe any non-controlled medication, including all primary bipolar medications, just as in-person doctors can.

Myth 2: ‘You’ll get medications without proper evaluation.’

Reality: Reputable telehealth services conduct thorough psychiatric evaluations, often more comprehensive than brief in-person visits.

Myth 3: ‘Bipolar medications are controlled substances like ADHD medications.’

Reality: The primary medications for bipolar disorder (lithium, lamotrigine, quetiapine) are not controlled substances and face fewer prescribing restrictions.

Myth 4: ‘Telehealth means lower quality care.’

Reality: Studies show telehealth mental health care can be equally effective, and providers must follow the same standard of care as in-person practitioners.

Red Flags to Watch For

When seeking telehealth treatment for bipolar disorder, be cautious if:

• The provider offers a specific medication before conducting a thorough evaluation
• The assessment seems rushed or lasts only a few minutes
• No emergency protocols or follow-up plan is established
• The provider seems dismissive of your questions or

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,this%20flexibility%20has%20been%20prolonged
• https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/#:~:text=,Internet%20without%20a%20valid%20prescription
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=In%20late%202024%2C%20the%20U,V
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=person%20evaluation%20requirement%20under%20the,provide%20short%20term%20stability%20while
• https://www.ama-assn.org/health-care-advocacy/advocacy-update/jan-24-2025-national-advocacy-update#:~:text=telemedicine%20registrations%20for%20prescribing%20Schedule,Like%20the%20buprenorphine%20rule
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=The%20Fourth%20Temporary%20Extension%2C%20along,flexibilities%20under%20the%20fourth%20temporary
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,long%20as%20the%20issuing%20provider
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,a
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=5,a%20physician%20must%20generally%20use